Health Innovation Networks lead national roll out of new kidney care service
Highlights
- Health innovation networks across England are rolling out an innovative kidney care service
- The LUCID programme will improve chronic kidney disease outcomes through early detection
- Health Innovation South West is working with partners in Cornwall to mobilise a programme to launch in 2027
All 15 health innovation networks across England are working together to roll out a successful care model to improve kidney care.
The LUCID – Connecting kidney care programme improves patient outcomes through early detection of chronic kidney disease (CKD), early intervention and optimisation, while maximising productivity and value for money.
New economic analysis from health economists, Frontier Economics, commissioned by the Health Innovation Network highlights the massive potential that could be achieved by rolling out the programme across England:
- £69.4m potential benefits in year one
- £334.9m potential benefits over five years
- Over five years, an estimated £3.25 return for every £1 invested.
In the South West of England, we are working with Devon, Cornwall and the Isles of Scilly Integrated Care Board cluster, industry, primary and secondary care, and the third sector in the county to mobilise an ambitious programme for launch in Spring 2027.
The model bridges the gap between primary and secondary care by integrating management of CKD. It has four main principles:
- LUCID multi-disciplinary team meetings (MDTs) are established, ensuring a more joined-up approach between hospital and GP practice care teams.
- Steps are put in place to identify patients more at risk of kidney disease.
- Training is provided for clinicians, and patients are better informed and able to manage their care.
- Ongoing healthcare management is optimised.
In the UK, over 3 million people live with the most severe stages of kidney disease and this is rising rapidly. People with kidney disease face increased risk of heart attack or stroke. The total annual economic burden of kidney disease in the UK is £7bn, with £6.4bn being direct costs to the NHS – about 3.2% of NHS budgets. (ref: https://www.kidneyresearchuk.org/about-us/policy/health-economics-report/)
For more information visit: Collaborating for chronic kidney disease care – Health Innovation South West
The original LUCID programme was developed through a Joint Working Agreement between the John Walls Renal Unit at University Hospitals of Leicester NHS Trust and AstraZeneca UK. That Joint Working project has concluded, and AstraZeneca UK has now signed a Memorandum of Understanding with Health Innovation East Midlands to share expertise and insights on the future implementation and scaling of LUCID.


